{"id":424087,"date":"2022-07-16T09:55:15","date_gmt":"2022-07-16T13:55:15","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=424087"},"modified":"2022-07-16T10:17:45","modified_gmt":"2022-07-16T14:17:45","slug":"vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/","title":{"rendered":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Asunci\u00f3n, Agencia IP.-<\/strong><\/em> En el Hospital de Cl\u00ednicas de la Facultad de Ciencias M\u00e9dicas UNA, se llev\u00f3 a cabo el cierre del estudio de Fase 3 de la vacuna taiwanesa MCV covid-19, del laboratorio taiwan\u00e9s Medigen Vaccine Biologics Corp. El proceso culmin\u00f3 con resultados \u00f3ptimos y buenas pr\u00e1cticas cl\u00ednicas.<\/p>\n<p style=\"text-align: justify;\"><!--more--><\/p>\n<p style=\"text-align: justify;\">A tal efecto, se discuti\u00f3 tanto el proceso como el an\u00e1lisis de todo lo ejecutado durante la realizaci\u00f3n del estudio, con la presencia del decano de la FCM-UNA, Osmar Cuenca, la vice-directora asistencial, F\u00e1tima Ovando, Julio Torales, investigador del estudio por FCM-UNA, Gladys Estigarribia, coordinadora del proyecto y representantes de la empresa VaxTrials, organismo encargado del monitoreo en la ejecuci\u00f3n del estudio y del cumplimiento de las buenas pr\u00e1cticas a nivel cl\u00ednico, entre otras personas que formaron parte de este proyecto .<\/p>\n<p style=\"text-align: justify;\">El decano de la FCM-UNA refiri\u00f3 que todo fue monitoreado por un equipo de profesionales, pertenecientes a la Facultad de Medicina, cerrando de esta manera el primer estudio de vacunas de Fase 3 a nivel pa\u00eds, con resultados \u00f3ptimos y con buenas pr\u00e1cticas cl\u00ednicas.<\/p>\n<p style=\"text-align: justify;\">En ese contexto, resalt\u00f3 que los resultados finales ser\u00e1n presentados a la sociedad cient\u00edfica y a la opini\u00f3n p\u00fablica en general en el Hospital de Cl\u00ednicas, a fin de exponer todo lo obtenido a lo largo de este tiempo de estudio y dedicaci\u00f3n.<\/p>\n<p style=\"text-align: justify;\">Es la primera vez que se lleva cabo algo de tal magnitud en Paraguay, lo cual es resaltante desde el punto de vista investigativo, sumado a los buenos resultados de las vacunas, siendo significativo para la comunidad investigativa de la Universidad Nacional de Asunci\u00f3n y por ende a esta instituci\u00f3n.<\/p>\n<h5 style=\"text-align: justify;\"><strong>Garant\u00eda de calidad<\/strong><\/h5>\n<p style=\"text-align: justify;\">Por su parte, Julio Torales, investigador principal del estudio de vacunas, explic\u00f3 que el mismo culmin\u00f3 de manera exitosa, demostr\u00e1ndose la calidad del trabajo realizado.<\/p>\n<p style=\"text-align: justify;\">Adem\u00e1s, el acompa\u00f1amiento de VaxTrials fue una garant\u00eda de la calidad del proceso de investigaci\u00f3n, lo que permite pensar en m\u00e1s investigaciones de este tipo, en el pa\u00eds.<\/p>\n<p style=\"text-align: justify;\">Torales destac\u00f3 adem\u00e1s que estuvieron trabajando m\u00e1s de 70 personas en todo este proyecto de vacunas anticovid, como investigadores, m\u00e9dicos, personal de enfermer\u00eda, equipo t\u00e9cnico, entre otros, todos los cuales se encuentran formados altamente en el procedimiento de aplicaci\u00f3n, as\u00ed como las buenas pr\u00e1cticas cl\u00ednicas.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asunci\u00f3n, Agencia IP.- En el Hospital de Cl\u00ednicas de la Facultad de Ciencias M\u00e9dicas UNA, se llev\u00f3 a cabo el cierre del estudio de Fase 3 de la vacuna taiwanesa MCV covid-19, del laboratorio taiwan\u00e9s Medigen Vaccine Biologics Corp. El proceso culmin\u00f3 con resultados \u00f3ptimos y buenas pr\u00e1cticas cl\u00ednicas.<\/p>\n","protected":false},"author":7,"featured_media":424088,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[10638,516,12814],"class_list":{"0":"post-424087","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nacionales","8":"tag-facultad-de-ciencias-medicas-una","9":"tag-hospital-de-clinicas","10":"tag-vacuna-taiwanesa-anticovid"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Asunci\u00f3n, Agencia IP.- En el Hospital de Cl\u00ednicas de la Facultad de Ciencias M\u00e9dicas UNA, se llev\u00f3 a cabo el cierre del estudio de Fase 3 de la vacuna taiwanesa MCV covid-19, del laboratorio taiwan\u00e9s Medigen Vaccine Biologics Corp. El proceso culmin\u00f3 con resultados \u00f3ptimos y buenas pr\u00e1cticas cl\u00ednicas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-16T13:55:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-16T14:17:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"717\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karina L\u00f3pez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karina L\u00f3pez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/\"},\"author\":{\"name\":\"Karina L\u00f3pez\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/613765cf13d420d448042e6802220539\"},\"headline\":\"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos\",\"datePublished\":\"2022-07-16T13:55:15+00:00\",\"dateModified\":\"2022-07-16T14:17:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/\"},\"wordCount\":416,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/vauna-taiwanesa-anticovid-fase-3.jpg\",\"keywords\":[\"Facultad de Ciencias M\u00e9dicas UNA\",\"Hospital de Clin\u00edcas\",\"Vacuna taiwanesa anticovid\"],\"articleSection\":[\"Nacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/\",\"name\":\"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/vauna-taiwanesa-anticovid-fase-3.jpg\",\"datePublished\":\"2022-07-16T13:55:15+00:00\",\"dateModified\":\"2022-07-16T14:17:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/vauna-taiwanesa-anticovid-fase-3.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/vauna-taiwanesa-anticovid-fase-3.jpg\",\"width\":1500,\"height\":717,\"caption\":\"Foto Gentileza\\\/ Hospital de Cl\u00ednicas\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/07\\\/16\\\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/613765cf13d420d448042e6802220539\",\"name\":\"Karina L\u00f3pez\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/klopez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/","og_locale":"es_ES","og_type":"article","og_title":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.","og_description":"Asunci\u00f3n, Agencia IP.- En el Hospital de Cl\u00ednicas de la Facultad de Ciencias M\u00e9dicas UNA, se llev\u00f3 a cabo el cierre del estudio de Fase 3 de la vacuna taiwanesa MCV covid-19, del laboratorio taiwan\u00e9s Medigen Vaccine Biologics Corp. El proceso culmin\u00f3 con resultados \u00f3ptimos y buenas pr\u00e1cticas cl\u00ednicas.","og_url":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2022-07-16T13:55:15+00:00","article_modified_time":"2022-07-16T14:17:45+00:00","og_image":[{"width":1500,"height":717,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg","type":"image\/jpeg"}],"author":"Karina L\u00f3pez","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"Karina L\u00f3pez","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/"},"author":{"name":"Karina L\u00f3pez","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/613765cf13d420d448042e6802220539"},"headline":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos","datePublished":"2022-07-16T13:55:15+00:00","dateModified":"2022-07-16T14:17:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/"},"wordCount":416,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg","keywords":["Facultad de Ciencias M\u00e9dicas UNA","Hospital de Clin\u00edcas","Vacuna taiwanesa anticovid"],"articleSection":["Nacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/","url":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/","name":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg","datePublished":"2022-07-16T13:55:15+00:00","dateModified":"2022-07-16T14:17:45+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/07\/vauna-taiwanesa-anticovid-fase-3.jpg","width":1500,"height":717,"caption":"Foto Gentileza\/ Hospital de Cl\u00ednicas"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/07\/16\/vacuna-taiwanesa-anticovid-culmino-estudio-de-la-fase-3-con-resultados-optimos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Vacuna taiwanesa anticovid: culmin\u00f3 estudio de la Fase 3 con resultados \u00f3ptimos"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/613765cf13d420d448042e6802220539","name":"Karina L\u00f3pez","url":"https:\/\/www.ip.gov.py\/ip\/author\/klopez\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/424087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=424087"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/424087\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/424088"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=424087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=424087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=424087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}